Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

Release date

September 15, 2020

Expiration date

September 14, 2021

Estimated Time to Complete

75 minutes

Number of Credits

1.25

Program Description

This activity provides guidance on how to better initiate individualized treatment for patients with type 2 diabetes that are hesitant to insulin initiation. Also reviewed are the most up-to-date insulin therapies and the current challenges and opportunities to improve diabetes care in diverse and underserved patient populations.

The faculty panel includes a set of multidisciplinary diabetes specialists that collaboratively treat patients. You will also hear from actual patients. Their perspectives will provide insight into the daily challenges and quality of life issues that can occur when a patient is considering initiating insulin therapy. Also included are simulations that model appropriate patient/provider communication and shared decision making.  

Intended Audience

Certified diabetes educators, endocrinologists, family physicians, primary care providers, nurses, nurse practitioners, pharmacists and physician assistants.

Educational Objectives

At the conclusion of this activity, participants will be able to (or better able to):

1. Describe psychological insulin resistance (PIR) from the standpoints of both provider and patient
2. Describe how low levels of adherence to therapeutic regimens in diabetes affect glycemic control and patient outcomes
3. Review negative patient outcomes beyond poor glycemic control that may occur in patients who demonstrate psychological insulin resistance and/or low adherence
4. Evaluate several evidence-based communicative strategies that may be employed in clinical practice to overcome barriers to insulin use

Accreditor Disclosure of Conflicts of Interest Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Nursing Continuing Professional Development (NCPD) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

Faculty Info

Katelyn O’Brien, PharmD, BCPS, CDE
Ambulatory Care Clinical Pharmacy Specialist
General Internal Medicine
Boston Medical Center
Boston, MA

Devin Steenkamp, MBChB
Assistant Professor of Medicine
Section of Endocrinology,
Diabetes and Nutrition
Boston University School of Medicine
Director of Clinical Diabetes,
Boston Medical Center
Boston, MA

Jason Worcester, MD
Course Director
Assistant Professor of Medicine
Boston University School of Medicine
Medical Director, Adult Primary Care
Boston Medical Center
Boston, MA

Faculty Disclosures

Dr. O’Brien has no relevant financial relationships to disclose.

Dr. Steenkamp is a consultant for Eli Lilly, is on the advisory board for Dexcom and receives research support from Novo Nordisk and Mylan.

Dr. Worcester has no relevant financial relationships to disclose.

Accreditor Disclosures

The following members of Boston University School of Medicine’s Office of Continuing Medical Education, have no relevant financial relationships to disclose:

Michael Burk, Senior Program Manager
Dana Frazier-Price MS, CHCP, Grant Development Manager
Christopher Drury, MA, MS, Consultant medical editor
Brian Jack, MD, AAFP Content Reviewer
Carmela A. Townsend, DNP, MS/MBA, RN, Lead Nurse Planner

Mary-Jane Kanaczet, M. Ed., Director, Office of Continuing Professional Development, College of Pharmacy, University of Rhode Island, has no relevant financial relationships to disclose.

Accreditation Statement

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This is a knowledge-based educational activity. Pharmacists will receive 1.25 contact hour (0.125 ceus) for the enduring educational activity. No partial credit is available. UAN: 0060-9999-20-020-H01-P

Disclosure of Unlabeled Use

Faculty members do not plan to discuss unlabeled/investigational uses of a commercial product.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

How to Earn Credit

Participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Grade Exam at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 80% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 80%, you will receive a message notifying you that you did not pass the post-test. You will have 3 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

For information about the accreditation of this program, please contact cme@bu.edu or www.bucme.org/

To view Boston University’s Privacy Policy, please see https://www.bucme.org/privacy

© Trustees of Boston University, 2020